Search research articles
Contact Us
Filters
Showing results (41-50 of 50) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 50 results.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
|
May 20, 2011
Procalcitonin as a potent marker of bacterial infection in febrile Afro-Caribbean patients at the emergency department
M Limper, M D de Kruif, N E Ajubi, et al.
American Journal of Hematology
|
September 11, 2002
No effect of acenocoumarol therapy on levels of endothelial activation markers in sickle cell disease
J B Schnog, M R Mac Gillavry, R A Rojer, et al.
Biochemical and Biophysical Research Communications
|
October 6, 2009
Plasma annexin A5 and microparticle phosphatidylserine levels are elevated in sickle cell disease and increase further during painful crisis
L J van Tits, W L van Heerde, P P Landburg, et al.
The Netherlands Journal of Medicine
|
January 29, 2016
Hepatitis E virus infection among blood donors in the South Caribbean: is screening warranted?
I Schreuder, M Limper, I Gerstenbluth, et al.
American Journal of Hematology
|
April 29, 2004
Protein C and S and inflammation in sickle cell disease
J B Schnog, M R Mac Gillavry, A P van Zanten, et al.
Arthritis and Rheumatism
|
December 1, 1995
Skewed distribution of IgG Fc receptor IIa (CD32) polymorphism is associated with renal disease in systemic lupus erythematosus patients
A J Duits, H Bootsma, R H Derksen, et al.
Haematologica
|
May 3, 2008
No association of the hypercoagulable state with sickle cell disease related pulmonary hypertension
E J van Beers, H M H Spronk, H Ten Cate, et al.
American Journal of Hematology
|
November 3, 1998
Elevated homocysteine levels indicate suboptimal folate status in pediatric sickle cell patients
F P van der Dijs, J J Schnog, D A Brouwer, et al.
Cancer Immunology, Immunotherapy : CII
|
June 1, 1995
CD8 T cell activation after intravenous administration of CD3 x CD19 bispecific antibody in patients with non-Hodgkin lymphoma
G C de Gast, I A Haagen, A A van Houten, et al.
American Journal of Hematology
|
January 5, 2002
Low adjusted-dose acenocoumarol therapy in sickle cell disease: a pilot study
J B Schnog, A P Kater, M R Mac Gillavry, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 50) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 50 results.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
|
May 20, 2011
Procalcitonin as a potent marker of bacterial infection in febrile Afro-Caribbean patients at the emergency department
M Limper, M D de Kruif, N E Ajubi, et al.
American Journal of Hematology
|
September 11, 2002
No effect of acenocoumarol therapy on levels of endothelial activation markers in sickle cell disease
J B Schnog, M R Mac Gillavry, R A Rojer, et al.
Biochemical and Biophysical Research Communications
|
October 6, 2009
Plasma annexin A5 and microparticle phosphatidylserine levels are elevated in sickle cell disease and increase further during painful crisis
L J van Tits, W L van Heerde, P P Landburg, et al.
The Netherlands Journal of Medicine
|
January 29, 2016
Hepatitis E virus infection among blood donors in the South Caribbean: is screening warranted?
I Schreuder, M Limper, I Gerstenbluth, et al.
American Journal of Hematology
|
April 29, 2004
Protein C and S and inflammation in sickle cell disease
J B Schnog, M R Mac Gillavry, A P van Zanten, et al.
Arthritis and Rheumatism
|
December 1, 1995
Skewed distribution of IgG Fc receptor IIa (CD32) polymorphism is associated with renal disease in systemic lupus erythematosus patients
A J Duits, H Bootsma, R H Derksen, et al.
Haematologica
|
May 3, 2008
No association of the hypercoagulable state with sickle cell disease related pulmonary hypertension
E J van Beers, H M H Spronk, H Ten Cate, et al.
American Journal of Hematology
|
November 3, 1998
Elevated homocysteine levels indicate suboptimal folate status in pediatric sickle cell patients
F P van der Dijs, J J Schnog, D A Brouwer, et al.
Cancer Immunology, Immunotherapy : CII
|
June 1, 1995
CD8 T cell activation after intravenous administration of CD3 x CD19 bispecific antibody in patients with non-Hodgkin lymphoma
G C de Gast, I A Haagen, A A van Houten, et al.
American Journal of Hematology
|
January 5, 2002
Low adjusted-dose acenocoumarol therapy in sickle cell disease: a pilot study
J B Schnog, A P Kater, M R Mac Gillavry, et al.
Page
of 5